Conclusion: This study enhances the understanding of the relative benefits and risks associated with various VaD treatments, providing a valuable reference for clinical decision-making.
PubMed 39239652 ↗Oxiracetam
The short answer. More people than not who report on Oxiracetam say it helped (66% of 218). It is most often used for focus: 90% of 148 reports say that improved. It is well studied — 5 meta-analyses on PubMed. The most common complaint is irritability.
From 495 mentions in total — the rest didn't say how it went and aren't counted.
What Oxiracetam does, according to users
Of the people who reported each effect, the share who said it got better.
2 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 5 meta-analyses on PubMed ↗ · 19 randomized trials ↗
Conclusion: Protocol Registration: PROSPERO (ID: CRD42019117178). Available online at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42019117178.
PubMed 31057392 ↗Conclusion: The most effective intervention for dementia available is symptomatic treatment for vascular dementia. Antipsychotic treatment for dementia alleviates cognitive dysfunction less effectively than does symptomatic treatment. Alternative therapies are also effective at present. Further research on causes and very early diagnosis of Alzheimer disease is warranted.
PubMed 29502274 ↗Conclusion: Conclusion: Our study demonstrated that ACEI inhibitors (Donepezil) and NMDA antagonists (Memantine), EGB761, and acupuncture are the ADL and BI, MoCA, and neurological function deficit medication/therapy, respectively, for patients with PSCI. Clinical Trial Registration: https://inplasy.com/inplasy-2022-11-0139/; Identifier: INPLASY2022110139.
PubMed 37693907 ↗2 human trials on ClinicalTrials.gov test Oxiracetam — 1 completed. See all on ClinicalTrials.gov ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Oxi gave me a significant increase in focus, to the point where I could work for 2-3 hours without even checking facebook. / It also helped me with memory (was clearly retaining more info in both short-term and long-term).”
“I took 2-3 750 mg of Oxiracetam a day...Similarly, I felt nothing.”
“Since I've been on this stack and changed my mindset and outlook in my life, everything has improved significantly.”
“When dosed I feel stimulated and logical. It was great when taken during my statistics class. I actually made less simple calculation errors during math tests.”
Top discussions (5)
Oxiracetam compared
Other options for focus
Sources
- User reports: 495 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate